ICU Medical Inc (ICUI)
179.20
+2.28
(+1.29%)
USD |
NASDAQ |
Oct 04, 16:00
179.25
+0.05
(+0.03%)
After-Hours: 20:00
ICU Medical SG&A Expense (TTM): 620.43M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 620.43M |
March 31, 2024 | 611.78M |
December 31, 2023 | 606.69M |
September 30, 2023 | 595.01M |
June 30, 2023 | 599.85M |
March 31, 2023 | 607.70M |
December 31, 2022 | 608.34M |
September 30, 2022 | 546.87M |
June 30, 2022 | 468.23M |
March 31, 2022 | 383.40M |
December 31, 2021 | 302.58M |
September 30, 2021 | 294.68M |
June 30, 2021 | 290.72M |
March 31, 2021 | 284.04M |
December 31, 2020 | 283.95M |
September 30, 2020 | 281.05M |
June 30, 2020 | 276.07M |
March 31, 2020 | 276.65M |
December 31, 2019 | 276.98M |
September 30, 2019 | 282.86M |
June 30, 2019 | 293.63M |
March 31, 2019 | 307.62M |
December 31, 2018 | 320.00M |
September 30, 2018 | 318.83M |
June 30, 2018 | 319.01M |
Date | Value |
---|---|
March 31, 2018 | 322.30M |
December 31, 2017 | 302.17M |
September 30, 2017 | 249.41M |
June 30, 2017 | 194.95M |
March 31, 2017 | 132.34M |
December 31, 2016 | 89.43M |
September 30, 2016 | 89.35M |
June 30, 2016 | 87.19M |
March 31, 2016 | 85.02M |
December 31, 2015 | 83.22M |
September 30, 2015 | 81.00M |
June 30, 2015 | 82.63M |
March 31, 2015 | 86.59M |
December 31, 2014 | 88.94M |
September 30, 2014 | 89.20M |
June 30, 2014 | 89.76M |
March 31, 2014 | 88.66M |
December 31, 2013 | 89.01M |
September 30, 2013 | 89.18M |
June 30, 2013 | 86.96M |
March 31, 2013 | 86.58M |
December 31, 2012 | 84.60M |
September 30, 2012 | 83.66M |
June 30, 2012 | 83.89M |
March 31, 2012 | 80.81M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
276.07M
Minimum
Jun 2020
620.43M
Maximum
Jun 2024
432.37M
Average
383.40M
Median
Mar 2022
SG&A Expense (TTM) Benchmarks
Outset Medical Inc | 132.37M |
Perspective Therapeutics Inc | 18.64M |
Retractable Technologies Inc | 19.15M |
Xtant Medical Holdings Inc | 79.82M |
Catheter Precision Inc | 10.84M |